Latest Insider Transactions at Gain Therapeutics, Inc. (GANX)
This section provides a real-time view of insider transactions for Gain Therapeutics, Inc. (GANX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Gain Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Gain Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 09
2024
|
Khalid Islam Executive Chairman |
BUY
Open market or private purchase
|
Direct |
50,000
+50.0%
|
$50,000
$1.0 P/Share
|
|
Aug 09
2024
|
Gene Mack CFO and Interim CEO |
BUY
Open market or private purchase
|
Direct |
14,400
+50.0%
|
$14,400
$1.01 P/Share
|
|
Jul 01
2024
|
Eric I Richman Director |
BUY
Open market or private purchase
|
Direct |
17,000
+2.87%
|
$17,000
$1.22 P/Share
|
|
Mar 28
2024
|
Jeffrey Scott Riley Director |
BUY
Open market or private purchase
|
Direct |
30,000
+50.0%
|
$90,000
$3.86 P/Share
|
|
Mar 26
2024
|
Matthias Alder Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,085
-22.35%
|
$24,340
$4.06 P/Share
|
|
Mar 26
2024
|
Matthias Alder Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,212
+15.81%
|
-
|
|
Dec 21
2023
|
Matthias Alder Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
206
-3.75%
|
$412
$2.46 P/Share
|
|
Dec 20
2023
|
Matthias Alder Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
637
+10.39%
|
-
|
|
Dec 07
2023
|
Matthias Alder Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,820
-27.27%
|
$3,640
$2.5 P/Share
|
|
Oct 01
2023
|
Matthias Alder Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
825
+11.0%
|
-
|
|
Sep 20
2023
|
Eric I Richman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
54,900
+16.76%
|
-
|
|
Sep 20
2023
|
Matthias Alder Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,550
+30.36%
|
-
|
|
Jul 01
2023
|
Matthias Alder Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,300
+50.0%
|
-
|
|
May 25
2022
|
Eric I Richman Director |
BUY
Open market or private purchase
|
Direct |
2,482
+1.13%
|
$4,964
$2.58 P/Share
|
|
May 20
2022
|
Eric I Richman Director |
BUY
Open market or private purchase
|
Direct |
9,256
+4.12%
|
$18,512
$2.83 P/Share
|
|
May 19
2022
|
Eric I Richman Director |
BUY
Open market or private purchase
|
Direct |
4,000
+1.9%
|
$8,000
$2.71 P/Share
|
|
May 19
2022
|
Salvatore Calabrese Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
3,000
+27.03%
|
$24,300,000
$8100.0 P/Share
|
|
Aug 16
2021
|
Eric I Richman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,922
+2.22%
|
$34,454
$7.87 P/Share
|